Atlas Trials

A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease

Clinical trial NCT07111013 · WITHDRAWN

Trial details

NCT number
NCT07111013
Sponsor
Bausch & Lomb Incorporated
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Dry Eye Disease
Start date
2025-12-01
Primary completion
2027-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.